NCT02721329View on ClinicalTrials.gov

Evaluation of APAP With SensAwake in OSA and Insomnia Patients

NACompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

March 31, 2020

Study Completion Date

March 31, 2020

Conditions
Obstructive Sleep ApneaInsomnia
Interventions
DEVICE

APAP

Automatic Continuous Positive Airway Pressure

DEVICE

APAP with SensAwake

Automatic Continuous Positive Airway Pressure with SensAwake enabled. SensAwake is a pressure relief technology that detects the transition from sleep to wake, and promptly reduces the pressure during wakeful periods.

Trial Locations (1)

Unknown

CHU Grenoble, Grenoble

All Listed Sponsors
collaborator

University Hospital, Grenoble

OTHER

collaborator

University Hospital, Angers

OTHER_GOV

lead

Fisher and Paykel Healthcare

INDUSTRY

NCT02721329 - Evaluation of APAP With SensAwake in OSA and Insomnia Patients | Biotech Hunter | Biotech Hunter